DULUTH, Ga., April 11 /PRNewswire/ -- Glades Pharmaceuticals has announced the appointment of Darren Alkins to the position of President. He will be responsible for all company activities including daily operations, strategy and business development activities related to the company's commercial initiatives.
"Darren's success is a result of his multifaceted pharmaceutical experience, high-energy, high-intensity and creative ability to find solutions," said Jeff Thompson, COO, Stiefel Laboratories. "These are excellent skill-sets and qualities that make Darren a spectacular choice for his new role."
Glades Pharmaceuticals will be reorganizing its management structure while adopting new protocol and processes for the company. At the same time, the generic pharmaceutical company remains committed to its mission of being a leader in pharmaceutical lifecycle management. The company creates innovative generic products by improving and expanding the use of known compounds and by aggressively adding to its pharmaceutical portfolio through development, licensing, acquisitions and collaborations.
"Glades is built around a philosophy of maximizing the lifecycle potential for pharmaceutical brands," said Alkins. "We are always looking for new partners who have a shared goal of improving the lives of patients and optimizing product value. We believe in equitable, balanced relationships. Glades will continue to invest long term in both its business and its partners."
Alkins has an extensive background in the pharmaceutical industry. He started his career as an intern at Bristol-Myers Squibb and spent the next 15 years with the company gaining expertise in both brand and generic sales, marketing, operations and business development. He then joined Glades Pharmaceuticals in June 2004 as Vice President, Business Development.
About Glades
Glades Pharmaceuticals was formed in 1991 and is a wholly-owned subsidiary of Stiefel Laboratories, Inc., the world's largest independent pharmaceutical company specializing in dermatology with global presence and more than 150 years of heritage and success. Glades specializes in the sales and marketing of safe and effective high-quality generic, branded-generic, and brand pharmaceutical products.
Glades PharmaceuticalsCONTACT: Erin Bacher of Ogilvy Public Relations Worldwide,+1-404-881-2324, or Erin.Bacher@ogilvypr.com, for Glades Pharmaceuticals
